venom time (RVTT), and kaolin clotting time (KCT) ( Table 1) .1 2 A diagnosis of SLE was considered likely. She improved with chloroquine phosphate (250 mg daily) and non-steroidal antiinflammatory drugs (NSAIDs) over the next three months.
In November 1985 she complained of unsteadiness of gait and difficulty in walking, with exacerbation of fever, polyarthritis, oral ulcers, and alopecia. All drugs (chloroquine and NSAIDs) were withdrawn. After two weeks she deteriorated with marked ataxia (truncal and limbs), nystagmus, and diplopia. Complete blood counts, blood urea, sugar, serum transaminases, alkaline phosphatase, electrocardiogram, chest and skull radiographs were normal. Urine analysis showed proteinuria (0-46 g/24 h). Antinuclear antibody test was positive (500 IU/mI), In March 1986, while receiving prednisolone 2-5 mg daily and chloroquine, she noticed the sudden onset of tinnitus and partial deafness, which gradually improved over four days. About three weeks later this recurred, then subsided gradually in a week. When examined a week later there were no signs except mild ataxia. Auditory brain stem and visual evoked responses were normal.
She remained well with prednisolone 5-10 mg daily, though serological activity (low C3, C4 concentrations, and high antinuclear antibody and anti-dsDNA titres) persisted. In January 1987 she developed an episode of intractable vomiting, abnormal behaviour, and dizziness, which improved after about two weeks without any specific treatment. At present she is asymptomatic.
No other associations of the lupus anticoagulantfor example, venous or arterial thrombosis, thrombocytopenia, pulmonary hypertension, positive Coombs' test, etc-were seen in the follow up. CASE A 20 year old girl presented iii August 1987 with fever and non-deforming polyarthritis (two years), malar rash, alopecia and Raynaud's phenomenon (six months), headache and severe pain in the left lower leg with paraesthesiae (15 days), tingling and numbness in the right foot, tremors in the left arm, unsteadiness of gait, and clumsiness in picking up objects with the left hand (four days). Her grandmother had definite rheumatoid arthritis. Examination showed cerebellar signs on the left side, more in the arm, and diminution of touch (15% in Si and L5 areas), pain (90% in Si ares), joint position (lost in big toe), and vibration sensation (lateral malleolus) on the right side.
Investigations showed a positive antinuclear antibody test (300 IU/ml, speckled pattern), positive anti-dsDNA (1/40 by passive hemagglutination), C3 320 mg/l, C4 160 mg/l; normal urine analysis, blood counts, liver and renal functions; negative lupus anticoagulant and raised cerebrospinal fluid protein (560 mg/l) and globulin. EEG, auditory brain stem and visual evoked responses were normal. Nerve conduction studies showed slowing of motor nerve conduction velocity in the right leg (posterior tibial, common peroneal), markedly prolonged F wave latency in the right leg, no response in the left leg, absent H reflex on both sides, compatible with bilateral multiple root involvement. Computed tomography scans of brain and lumbosacral spine were normal.
She was treated with prednisolone 30 mg daily and carbamazepine 600 mg in divided doses. Her cerebellar symptoms gradually subsided, but she continued to have root pains till her last visit (November 1987).
Discussion
Although neuropsychiatric manifestations are very common (up to 75%) in SLE, cerebellar dysfunction has rarely been described.A8
The sudden onset of nystagmus, ataxia, and other cerebellar signs in our patients suggested cerebellar involvement. The clinical and laboratory findings suggested that SLE was the most likely cause of this. Moreover, EEG abnormality and an episode of tinnitus and deafness in case 1, peripheral neuropathy in case 2 and radiculopathy in case 3 suggest a more generalised involvement of the nervous system.
A variety of mechanisms have been suggested as possible pathogenetic factors in central nervous system involvement in SLE. 8 Corticosteroids given at presentation seemed to ameliorate the cerebellar signs in cases 3 and 1, while the residual cerebellar dysfunction seen in case 2 might have been due to starting treatment late.
Clearly, patients presenting with cerebellar dysfunction of no obvious cause, and especially those with features of systemic immunoinflammation, should be investigated for SLE. 
